| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4341173 | Neuroscience | 2007 | 10 Pages |
Abstract
These results confirm that targeting the JNK cascade using the TAT cell-penetrating peptide offers a promising therapeutic approach for ischemia, raising hopes for human neuroprotection, and elucidates the molecular pathways leading to and following JNK activation.
Keywords
Related Topics
Life Sciences
Neuroscience
Neuroscience (General)
Authors
M. Repici, C. Centeno, S. Tomasi, G. Forloni, C. Bonny, A. Vercelli, T. Borsello,